NICE has updated its advice on two therapeutics for managing COVID-19 – remdesivir and colchicine.
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
- New advice in the last 6 months (1)
- Updated advice in the last 6 months (0)
- In development advice (0)
Set out priority areas for quality improvement in health and social care.
- New quality standards in the last 6 months (0)
- Updated quality standards in the last 6 months (0)
- In development quality standards (0)
Interactive topic-based flowcharts that allow you to navigate our recommendations on any subject.
Guidance by programme
Advice by programme
Products being developed or updated
Guidance, quality standards and advice being developed.
News and blogs
News on this topic
One year on from the first national lockdown, NICE has today (23 March) published a single guideline for the management of COVID-19 in children and adults.
Healthcare professionals should consider the risk of antimicrobial resistance when deciding whether antibiotics are needed for treating or preventing a flare up of symptoms of chronic obstructive pulmonary disease (COPD).
Blogs on this topic
Rosie explains how new NICE guidance will help us all in the fight against antibiotic resistance
Di has been working hard to teach her students about the importance of hand-washing. Find out how she has got on.
Putting guidance into practice
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 3 of 21 shared learning examples for this topic: